Glimicron (TN)
Glimicron (TN) Brand names, Glimicron (TN) Analogs
- 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
- 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
- Diamicron
- Gliclazida [INN-Spanish]
- Gliclazide (JAN)
- Gliclazide [BAN:DCF:INN:JAN]
- Gliclazidum [INN-Latin]
- Glimicron
- Glimicron (TN)
- N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea
- Nordialex
Glimicron (TN) Brand Names Mixture
- No information avaliable
Glimicron (TN) Chemical_Formula
C15H21N3O3S
Glimicron (TN) RX_link
No information avaliable
Glimicron (TN) fda sheet
Glimicron (TN) msds (material safety sheet)
Glimicron (TN) Synthesis Reference
No information avaliable
Glimicron (TN) Molecular Weight
323.412 g/mol
Glimicron (TN) Melting Point
181 oC
Glimicron (TN) H2O Solubility
No information avaliable
Glimicron (TN) State
Solid
Glimicron (TN) LogP
2.418
Glimicron (TN) Dosage Forms
Tablet
Glimicron (TN) Indication
For the treatment of Diabetes mellitus
Glimicron (TN) Pharmacology
Gliclazide is a second generation sulphonylurea which acts as a hypoglycemic agent. It stimulates beta cells of the islet of Langerhans in the pancreas to release insulin. It also enhances peripheral insulin sensitivity. Overall it potentiates insulin release and improves insulin dynamics.
Glimicron (TN) Absorption
Rapidly and well absorbed but may have wide inter- and intra-individual variability.
Glimicron (TN) side effects and Toxicity
LD50=3000 mg/kg (orally in mice)
Glimicron (TN) Patient Information
No information avaliable
Glimicron (TN) Organisms Affected
Humans and other mammals
